Sociodemographic and clinical factors associated with relapse in schizophrenia
|
|
- Sydney Jacobs
- 5 years ago
- Views:
Transcription
1 Psychiatry and Clinical Neurosciences (2007), 61, doi: /j x Regular Article Sociodemographic and clinical factors associated with relapse in schizophrenia GOBIND CHABUNGBAM, md, AJIT AVASTHI, md AND PRATAP SHARAN, md, phd Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh, India Abstract The aim of the present study was to examine sociodemographic and clinical factors associated with relapse in schizophrenia. The study group consisted of a convenience sample of 40 schizophrenia patients (20 patients each in relapse and remission). Relapse and remission were defined based on clinical criteria (ICD-10 criteria, course since last episode, and duration of remission) and psychometric criteria (scores on Socio-Occupational Functioning Assessment Scale [SOFAS] and Positive and Negative Syndrome Scale for Schizophrenia [PANSS]). The index group was evaluated after the occurrence of current relapse but within 6 months of its onset. Sociodemographic, current psychopathology (PANSS) and functioning (SOFAS), and other (mainly retrospective) variables were assessed with a specifically designed clinical profile sheet, Schedule for Affective Disorders and Schizophrenia Lifetime version, Presumptive Stressful life Events Scale, and World Health Organization Life Chart Schedule for Assessment of Course and Outcome of Schizophrenia. Patients who had relapsed were more symptomatic and exhibited greater dysfunction in comparison to remitted patients. Relapse in schizophrenia was significantly associated with unemployment, number of psychotic episodes, side-effects of medication, and life events score. The present findings suggest that a severe illness (no. psychotic episodes, unemployment), psychological stress and inappropriate treatment (side-effects of medicines) may be causally related to relapse in schizophrenia. However, the possibility that these variables may be caused by relapse or may be explained by a common underlying variable needs to be assessed prospectively. Key words life events, predictors, relapse, remission, schizophrenia. INTRODUCTION Relapses in schizophrenia predict poor prognosis, bring about deterioration in social, occupational and financial status and increase the burden of care on the family. Relapse has been defined variably by researchers, for example clinical deterioration of such magnitude that hospitalization was imminent; 1 a return to medication; 2 a return of the disorder with a re-emergence of florid psychotic features and gross social decomposition leading to a change in treatment and hospitalization. 3 This has contributed to inconsistency in findings. Correspondence address: Ajit Avasthi, MD, Department of Psychiatry, Postgraduate Institute of Medical Education and Research, Chandigarh , India. pratapsharan@yahoo.com Received 13 July 2006; revised 12 June 2007; accepted 20 June Mortensen and Eaton found that readmission risk decreased with increasing age at first schizophrenia admission till the fifth discharge but no effect was found at later admissions. 4 Moller et al. reported that age >40 years reduced the risk of re-hospitalization, and age >30 years reduced the rate of relapse in patients on maintenance treatment. 5 Angermeyer et al. reported that in one-third of 18 comparison studies on schizophrenia, women had lower rates of rehospitalization than men, 6 whereas only two studies found the opposite result. 4,7 Some studies have shown that living in a partnership predicted a better outcome. 5,8 However, in many other studies marital status did not predict readmission risk Readmission risk was lower after the first discharge for the simple, paranoid, and latent subtypes than for other groups. 4 Diagnosis of residual type (ICD-9) decreased the risk of relapse. 7 Comorbid substance use disorder was associated with early readmission. 12
2 588 G. Chabungbam et al. Subjective feeling of depression during the first admission, number of depressive episodes, depression developing within 1 year of recovery from a schizophrenia episode, and suicide attempts were associated with either early relapse or readmission during follow up in various studies. 7,13 15 However, the presence of depressive delusions during a schizophrenia episode seemed to protect against an early relapse. 13 Patients in families with high expressed emotion are more likely to relapse and to relapse more often, 16,17 but expressed emotion, in all likelihood, is a weak predictor of relapse Similarly, while some studies have shown a significant association between number of independent life events and schizophrenia relapse, 21,22 other studies have found no such association. 23,24 Ventura et al. found life events to be significant predictors of relapse in patients on medication but not in patients off medication. 25 Medication discontinuation is a risk factor for schizophrenia relapse. 26,27 However, Prien et al. reported that only 6% of patients relapsed on high doses (2000 mg/day) and 13% on low doses (300 mg/ day) of chlorpromazine. 27 Other treatment variables may also be important. Early readmission was associated with four or more previous hospitalizations and absence of a family meeting with inpatient staff. 12 Functional status before onset of schizophrenia (poor school adaptation in childhood and late adolescence) and after the onset of schizophrenia (period of unemployment) has also been observed to be associated with relapse and readmission. 5,28 30 Identification of factors associated with relapse is important to develop modalities for relapse prevention. The present study was conducted to examine sociodemographic and clinical factors associated with rigorously defined relapse in schizophrenia. METHODS The sample for the present study was taken from psychiatric outpatient and inpatient services of the Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh, a tertiary care center located in north-western India. The index group consisted of a convenience sample of 20 patients with schizophrenia presenting in relapse, and the control group consisted of 20 patients with schizophrenia presenting in remission. The Institute Ethics Committee approved the protocol for the research project and the work was undertaken within its guidelines, and it conforms to the provisions of the Declaration of Helsinki in 1995 (as revised in Edinburgh 2000). All subjects or their legal guardian (in the case that the subject was incompetent to give consent) gave written informed consent and patient anonymity was preserved. Relapse was defined as (i) presence of 1 criterion from the A D group or presence of 2 criteria from the E H group of ICD-10 criteria for schizophrenia lasting for at least 1 week; 31 (ii) Socio-Occupational Functioning Assessment Scale (SOFAS) level of 70; 32 (iii) Positive and Negative Syndrome Scale for Schizophrenia (PANSS) positive subscale score 13; 33 (iv) following a period of remission of at least 2 months in which there was absence of any A D criteria and 2 E H criteria for schizophrenia in ICD-10; (v) with the current relapse not being the first expression of schizophrenia psychosis. Remission was defined as (i) absence of A D criteria and absence of 2 E H criteria for schizophrenia in ICD-10; (ii) SOFAS >70; (iii) PANSS positive subscale score 12; (iv) no change in medication by >50% and no hospitalization; and (v) duration of at least 2 months. All the five criteria had to be fulfilled for the identification of relapse or remission. Patients in both groups were of either sex between the ages of 18 and 55 years. Patients with clinical evidence of concomitant major psychiatric illness, substance abuse (excluding tobacco), organic brain syndrome, mental retardation, major physical illness or incapacitation were excluded from the study. Patients in the index group were evaluated after the onset of current relapse but within 6 months of its onset. Information was collected on the following classes of variable: (i) sociodemographic variables; (ii) current psychopathology (PANSS) and functioning (SOFAS); and (iii) other (mainly retrospective) variables with the help of a specifically designed clinical profile sheet, and also Schedule for Affective Disorders and Schizophrenia Lifetime version (SADS-L), 34 Presumptive Stressful life Events Scale (PSLES), 35 and World Health Organization (WHO) Life Chart Schedule for Assessment of Course and Outcome of Schizophrenia (WHO-LCS). 36 The PANSS consists of three subsets of items, that is, for positive symptoms, negative symptoms and general psychopathology. 32 SOFAS focuses exclusively on the individual s level of social and occupational functioning, and is not directly influenced by the overall severity of the individual s psychological symptoms. 33 The clinical profile sheet specifically designed for the present study was used to record the following variables: age at onset, duration of illness, family history of schizophrenia, subcategory of schizophrenia, and medication (status, type, dose, side-effects). SADS-L generates diagnoses of major psychiatric disorders based on information relevant to diagnosis, prognosis and phenomenology of current and past episodes of illness. 34
3 Factors affecting schizophrenic relapse 589 PSLES is an inventory of 51 items from which scores on desirable, undesirable and ambiguous and also personal and impersonal categories can be derived. 35 Normative data from north-western India are available for comparisons. WHO-LCS provides information about specific areas such as work, residence, symptoms and treatment since first treatment contact. It is a valid and reliable test for assessment of course and outcome of patients with schizophrenia. 36 Unpaired Student s t-test was applied for group comparisons on continuous variables. Fisher s exact test was applied for categorical variables. Significance was set at P < 0.05 (two-tailed test). RESULTS Demographic variables The majority of the patients in the relapsed and remitted groups of schizophrenia, respectively, were male (>60%), literate (>80%), employed (>50%), Hindu (>70%); and from an urban background (>65%). Only a minority were married (<45%). Monthly income in the majority (>70%) was below Rupees 3000 (approximately US$60). The mean age of the patients in the relapsed and remitted schizophrenia groups was years and years, respectively. The two groups did not differ significantly on sociodemographic variables (Table 1). Current psychopathology and functioning The relapsed group had significantly higher positive syndrome; general psychopathology; negative syndrome, anergic and paranoid feature scores in comparison to the remitted group (Table 2).The majority (55%) of patients in the relapsed group had moderate impairment in socio-occupational function, while the majority in the remitted group had functioning in the superior to mild impairment range. The difference between the two groups was statistically significant (Table 2). Other (mainly retrospective) variables There was no significant difference between the relapsed and remitted groups, in terms of presence or absence of psychopathology elicited on the SADS-L: persecutory delusions (95%, each), somatic, grandiose, religious or other delusions without persecutory or jealous content, lasting at least 1 week (35% and 30%, respectively), delusions of being controlled (or influenced), multiple delusions, or other bizarre delusions (20% and 30%, respectively), delusions of any type Table 1. Subject characteristics Variable Fisher s exact P Gender 0.74 Male 14 (70) 12 (60) Female 6 (30) 8 (40) Marital status 0.32 Single 15 (75) 11 (55) Married 5 (25) 9 (45) Occupation 1.00 Employed 11 (55) 10 (50) Unemployed 9 (45) 10 (50) Education 0.34 Illiterate 4 (20) 1 (5) Literate 16 (80) 19 (95) Income (Rupees/month) (70) 15 (75) > (30) 5 (25) Religion 0.45 Hinduism 14 (70) 17 (85) Others 6 (30) 3 (15) Locality 0.27 Urban 17 (85) 13 (65) Rural 3 (15) 7 (35)
4 590 G. Chabungbam et al. Table 2. Psychopathological dimensions and stressful life events Variables Mean SD Mean SD Statistic PANSS score Positive syndrome *** General psychopathology * Negative syndrome * Anergia * Thought disturbance Activation Paranoid *** Depression SOFAS categories Superior functioning to mild impairment 0 (0) 17 (85) 30.57*** Moderate impairment 11 (55) 3 (15) Severe impairment to incapacitation 9 (45) 0 (0) * P < 0.05, ** P < 0.01, *** P < t (d.f. = 38); c 2 (d.f. = 2). PANSS, Positive and Negative Syndrome Scale; SOFAS, Socio-Occupational Functioning Assessment Scale. accompanied by hallucinations of any type lasting for at least 1 week (25% and 20%, respectively), hallucinations of any type throughout the day for several days, or intermittently for at least 1 month (80% and 65%, respectively), visual hallucinations (25% and 15%, respectively), auditory hallucinations (85% and 75%, respectively), auditory hallucinations commenting/ discussing (70% and 75%, respectively), non-affective verbal hallucination spoken to the subject (30% and 5%, respectively), thought broadcasting/withdrawal/ insertion (20% and 50%, respectively), definite instances of formal thought disorder (10%, each), catatonic motor behavior (10% and 15%, respectively) and grossly bizarre behavior (30% and 10%, respectively; data not shown). The interview, assisted by the specifically designed clinical profile sheet, showed that significantly more patients in the relapsed group had moderate to severe side-effects in comparison to remitted patients (Table 3). The relapsed group also reported significantly higher stress scores than the remitted patient group on PSLES (Table 4). The relapsed group had significantly more unemployment due to mental illness and higher mean number of psychotic episodes in comparison to the remitted group (Table 5). DISCUSSION The relapsed and remitted patient groups did not differ significantly in terms of sociodemographic variables. The occurrence of significant difference between relapsed and remitted groups in positive syndrome score and current level of functioning was mandated by our definition of relapse. The higher general psychopathology, negative syndrome, anergic and paranoid feature scores on PANSS in the relapsed patient group as compared to the remitted patient group, although not mandated by our definition of relapse, attest only to the likelihood that the symptom cluster of schizophrenia is of a syndromal nature. In the present study, subtype of schizophrenia did not differ between the relapsed and remitted groups, unlike in some previous studies. 4,7 The small sample size in the present study and the risk of type II error, limit the confidence that can be placed on negative statistical findings. The significant difference in the relapsed and remitted groups in PANSS scores and the absence of such differences in psychopathology in SADS lifetime interview could be due to variation in period of assessment (cross-sectional vs lifetime), variation in rating methods (dimensional vs categorical) and possibility of recall bias (accurate assessment vs retrospective falsification). The relapsed group had significantly greater number of psychotic episodes in comparison to the remitted group. However, the present study failed to find any association between the number of previous hospitalizations (>4) and relapse, unlike some previous studies. 7,12 The apparent paradox becomes less puzzling when we consider the fact that most psychotic relapses are treated on an outpatient basis in
5 Factors affecting schizophrenic relapse 591 Table 3. Clinical subject features Variable Statistic Age at onset (years), mean SD Duration of the illness (years), mean SD Family history of schizophrenia 0.06 Present 8 (40) 2 (10) Absent 12 (60) 18 (90) Subtype of schizophrenia 0.54 Paranoid 11 (55) 13 (65) Others 9 (45) 7 (35) Medication 0.11 Receiving 16 (80) 20 (100) Not receiving 4 (20) 0 (0) Type of medication 0.73 Antipsychotic only 9 (56.25) 13 (65) Antipsychotic + other drugs 7 (43.75) 7 (35) Dosage (CPZ equivalent) mg/day (43.75) 5 (25) >300 9 (56.25) 15 (75) Compliance 0.15 Good 10 (62.5) 17 (85) Poor 6 (37.5) 3 (15) Side-effects 0.03* Minimal 10 (62.5) 19 (95) Moderate to severe 6 (37.5) 1 (5) * P < t (d.f. = 38); Fisher s exact test (P). n = 16 in relapsed group. CPZ, chlorpromazine. Table 4. PSLES scores PSLES score Mean SD Mean SD t (d.f. = 38) Undesirable items score Desirable items score Ambiguous items score Total score * * P < PSLES, Presumptive Stressful life Events Scale. India, unlike in the West, where a closer correspondence between relapse and admission would be seen. Relapsed patients reported significantly more moderate severe side-effects of medication as compared to patients in the remitted group. Presence of greater side-effects may be the result of increase in dose of antipsychotics to combat relapse, or the cause of non-compliance that may have led to the relapse. Earlier studies have reported discontinuation of medication and ultra low dosage of antipsychotics to be significant predictors of relapse in patients with schizophrenia. 26,37,38 However, there was no significant difference between the two groups in terms of medication
6 592 G. Chabungbam et al. Table 5. Life course variables Variable Statistic Psychotic episodes (mean SD) * Suicide attempts 1.00 Yes 17 (85) 16 (80) No 3 (15) 4 (20) Months in hospital for psychiatric problems (mean SD) Hospital admission for psychiatric problem 1.00 <4 9 (90) 6 (100) 4 1 (10) 0 (0) Unemployed 0.30 Sometimes 8 (40) 4 (20) Never 12 (60) 16 (80) Unemployment related to mental illness 0.02* Not at all/a little 0 (0) 3 (75) Some/a lot 8 (100) 1 (25) Social relations (5 years) 1.00 Fair to superior 16 (80) 17 (85) Poor/grossly inadequate 4 (20) 3 (15) Level of functioning (5 years) 0.14 Absent/minimal/mild 18 (90) 14 (70) Moderate impairment 2 (10) 6 (30) * P < t (d.f. = 38); Fisher s exact test (P). n = 8 in relapsed group, n = 4 in remitted group; n = 10 in relapsed group, n = 6 in remitted group. intake during the 6 months prior to evaluation in the present study. The occurrence of significantly higher number of life events during the previous 6 months in the relapsed group in comparison to the remission group was consistent with previous reports. 21,22,25 A longer period of unemployment was reported to be a reliable predictor of re-hospitalization rate in some studies. 5,29,30 Significantly more relapsed patients had become unemployed due to their mental illness in comparison to the remitted group. It is likely that (repeated) relapse(s) had interfered with their occupational functioning. However, it is also possible that the relapsed group may be retrospectively magnifying their occupational dysfunction. The recruitment of a small sample resulted in difficulties in interpreting the findings (type II errors). Use of a convenience sample could have resulted in skewed data. The present findings suggest that a severe illness (number of psychotic episodes, unemployment), psychological stress and inappropriate treatment (sideeffects of medicines) may be causally related to relapse in schizophrenia. However, prospective studies are needed to establish the causal independence of these variables, and multivariate techniques may lead to the identification of common underlying variables that may explain the effect of many predictor variables. REFERENCES 1. Hogarty G, Goldberg S, Collaborative Study Group A. Drug and sociotherapy in the aftercare of schizophrenic patients: One year relapse rates. Arch. Gen. Psychiatry 1973; 28: Gilbert P, Harris M, McAdams L et al. Neuroleptic withdrawal in schizophrenic patients: A review of the literature. Arch. Gen. Psychiatry 1995; 52: Lader M. What is relapse in schizophrenia? Int. Clin. Psychopharmacol. 1995; 48: Mortensen PB, Eaton WW. Predictors for readmission risk in schizophrenia. Psychol. Med. 1994; 24: Moller HJ, Werner-Eilert K, Wuschner-Stockheim M et al. Relevant predictors of the 5-year outcome of patients with schizophrenia or similar paranoid psychoses. Arch. Psychiatr. Nervenkr. 1982; 231: Angermeyer MC, Goldstein JM, Kuehn L. Gender difference in schizophrenia: Rehospitalization and community survival. Psychol. Med. 1989; 19: Doering S, Muller E, Kopcke W et al. Predictors of relapse and rehospitalization in schizophrenia and schizoaffective disorder. Schizophr. Bull. 1998; 24:
7 Factors affecting schizophrenic relapse Biehl H, Maurer K, Schubart C, Krumm B, Jung E. Prediction of outcome and utilization of medical services in a prospective study of first onset schizophrenics. Eur. Arch. Psychiatry Clin. Neurosci. 1986; 236: Eaton WW, Mortensen PB, Herrman H et al. Long-term course of hospitalization for schizophrenia. Part 1: risk for rehospitalization following first discharge for schizophrenics in four register areas. Schizophr. Bull. 1992; 18: Kulhara P, Chandiramini K. Outcome of schizophrenia in India using various diagnostic systems. Schizophr. Res. 1988; 1: Rosen B, Klein DF, Gittleman-Klein R. The prediction of rehospitalization: The relationship between age of first psychiatric treatment contact, marital status and premorbid social adjustment. J. Nerv. Ment. Dis. 1971; 152: Olfson M, Mechanic D, Boyer CA et al. Assessing clinical predictions of early hospitalizations in schizophrenia. J. Nerv. Ment. Dis. 1999; 187: Geddes J, Mercer G, Fruith CD et al. Prediction of outcome following a first episode of schizophrenia: A follow-up study of Northwick Park First Episode Study Subjects. Br. J. Psychiatry 1994; 165: Shepherd M, Watt D, Falloon I et al. The natural history of schizophrenia: A five year follow-up study of outcome and prediction in a representative sample of schizophrenias. Psychol. Med. 1989; 19 (Suppl. 15): Johnson DAW. The significance of depression in the prediction of relapse in chronic schizophrenia. Br. J. Psychiatry 1988; 152: Vaughn CE, Left JP. The influence of family and social factors on the course of psychiatric illness: A comparison of schizophrenia and depressed neurotic patients. Br. J. Psychiatry 1976; 129: McCreadie RG, Phillips K. The Nithsdale Schizophrenia Survey. VII. Does relatives high expressed emotion predict relapse. Br. J. Psychiatry 1988; 152: MacMillan JF, Gold A, Crow TZ et al. Expressed emotion and relapse. Br. J. Psychiatry 1986; 148: Tarrier N, Barraclough C, Porceddu K et al. The Salford Family Intervention Project: Relapse rates of schizophrenia at five and eight years. Br. J. Psychiatry 1994; 165: Montero I, Gomez-Beseyto M, Ruiz J et al. The influence of family expressed emotion on the course of schizophrenia in a sample of Spanish patients: A two year follow up study. Br. J. Psychiatry 1992; 161: Brown GW, Birley J. Crises and life changes and the onset of schizophrenia. J. Health Soc. Behav. 1968; 9: Bebbington PE, Wilkins S, James P et al. Life events and psychosis: Initial results from the Camberwell Collaborative Psychosis Study. Br. J. Psychiatry 1992; 162: Hirsch SR, Cramer P, Bowen JT. The triggering hypothesis of the role of life events in schizophrenia. Br. J. Psychiatry 1992; 161 (Suppl. 18): Malla AK, Cortese TS, Ginsberg G. Life events and relapse in schizophrenia. A one year prospective study. Soc. Psychiatry Psychiatr. Epidemiol. 1990; 25: Ventura J, Nuechterlein KH, Luroff D et al. A prospective study of stressful life events in schizophrenia relapse. J. Abnorm. Psychol. 1989; 98: Hogarty G, Ulrich R. Temporal effects of drug and placebo in delaying relapse in schizophrenic outpatients. Arch. Gen. Psychiatry 1977; 34: Prien R, Cole J, Belkin F. Relapse in schizophrenics following abrupt withdrawal of tranquilizing medications. Br. J. Psychiatry 1968; 115: Robinson D, Worner MG, Alver JMJ et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 1999; 6: Scottish Schizophrenia Research Group. The Scottish First Episode Schizophrenia study VIII: Five year followup: clinical and psychosocial findings. Br. J. Psychiatry 1992; 61: Jonsson H, Nyman AK. Predicting long-term outcome in schizophrenia. Acta Psychiatr. Scand. 1991; 83: World Health Organization. The International Statistical Classification of Diseases and Related Health Problems, Tenth Revision (ICD-10). World Health Organization, Geneva, Kay SR, Opler A, Fiszbein A. Positive and Negative Syndrome Scale (PANSS). Department of Psychiatry, Albert Einstein College and Medical Centre and Schizophrenia Research Unit, New York, American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn (DSM-IV). American Psychiatric Press, Washington DC, Endicott J, Spitzer RL. A diagnostic interview: The schedule for affective disorders and schizophrenia. Arch. Gen. Psychiatry 1978; 35: Singh G, Kaur D, Kaur H. Presumptive stressful life events scale for use in India. Indian J. Psychiatry 1984; 26: Susser E, Conover S, Siegel C et al. WHO Life Chart Schedule for Assessment of Course and Outcome of Schizophrenia. Nathan S, Klein Institute for Psychiatric Research, Orangeburg, New York, Thara R, Henrietta M, Joseph A et al. Ten year course of schizophrenia: The Madras longitudinal study. Acta Psychiatr. Scand. 1994; 90: Kane J, Woerner M, Sarantakos S. Depot neuroleptics: A comparative review of standard, intermediate and low dose medication. J. Clin. Psychiatry 1986; 47 (Suppl.):
EVALUATION OF WORRY IN PATIENTS WITH SCHIZOPHRENIA AND PERSECUTORY DELUSION COMPARED WITH GENERAL POPULATION
Bulletin of the Transilvania University of Braşov Series VI: Medical Sciences Vol. 7 (56) No. 1-2014 EVALUATION OF WORRY IN PATIENTS WITH SCHIZOPHRENIA AND PERSECUTORY DELUSION COMPARED WITH GENERAL POPULATION
More informationBizarre delusions and DSM-IV schizophrenia
Psychiatry and Clinical Neurosciences (2002), 56, 391 395 Regular Article Bizarre delusions and DSM-IV schizophrenia MAKOTO NAKAYA, md, phd, 1 KATSUNORI KUSUMOTO, md, phd, 2 TAKAYUKI OKADA, md, phd 3 AND
More informationPsychotic Disorders. Schizophrenia. Age Distribution of Onset 2/24/2009. Schizophrenia. Hallmark trait is psychosis
Psychotic Disorders Schizophrenia Schizophrenia Affects people from all walks of life Is about as prevalent as epilepsy Usually begins in late adolescence or early adulthood Hallmark trait is psychosis
More informationInitial Prodrome Description in Recent Onset Schizophrenia
Amr El-Shribiny et al. Initial Prodrome Description in Recent Onset Schizophrenia Amr M M El-Shribiny, Salwa M. Rabie, Hanaa S. Soliman, Refaat Mahfouz Department of Neurology and Psychiatry, El-Minia
More informationPsychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com
Psychotic disorders Dr. Sarah DeLeon, MD PGYIV, Psychiatry ConceptsInPsychiatry.com Introduction Psychotic spectrum disorders include schizotypal personality disorder, delusional disorder, brief psychotic
More informationALCOHOLIC HALLUCINOSIS AND PARANOID SCHIZOPHRENIA A PARATIVE (CLINICAL AND FOLLOW UP) STUDY
Mun J. Pnckiiu. {1), 2(4), S W2 ALCOHOLIC HALLUCINOSIS AND PARANOID SCHIZOPHRENIA A PARATIVE (CLINICAL AND FOLLOW UP) STUDY COM-* G. SAMPATH* MD Y. VIKRAM KUMAR" DM* S. M. CHANNABASAVANNA* MD M.S. KESHAVAN*
More informationD. Exclusion of schizoaffective disorder and mood disorder with psychotic features.
65 CHAPTER 8: APPENDIX. ADDENDUM A DSM-IV diagnostic criteria for schizophrenia A. Characteristic symptoms: Two or more of the following, each present for a significant portion of time during a one-month
More informationA Comparative Study of Socio Demographic and Clinical Profiles in Patient with Obsessive Compulsive Disorder and Depression
American Journal of Psychiatry and Neuroscience 2018; 6(4): 99-103 http://www.sciencepublishinggroup.com/j/ajpn doi: 10.11648/j.ajpn.20180604.12 ISSN: 2330-4243 (Print); ISSN: 2330-426X (Online) A Comparative
More informationBADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0)
BADDS Appendix A: The Bipolar Affective Disorder Dimensional Scale, version 3.0 (BADDS 3.0) General information The Bipolar Affective Disorder Dimension Scale (BADDS) has been developed in order to address
More information4. General overview Definition
4. General overview 4.1. Definition Schizophrenia is a severe psychotic mental disorder characterized by significant disturbances of mental functioning. It has also been called early dementia, intrapsychic
More informationBurden among Caregivers of Person with Schizophrenia and. Schizoaffective Disorder: A Comparative Study
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 2, Issue 4, DIP: B00388V2I42015 http://www.ijip.in July September, 2015 Burden among Caregivers of Person with
More informationChapter 12. Schizophrenia and Other Psychotic Disorders. PSY 440: Abnormal Psychology. Rick Grieve Western Kentucky University
Chapter 12 Schizophrenia and Other Psychotic Disorders PSY 440: Abnormal Psychology Rick Grieve Western Kentucky University psychotic disorders disorders so severe that the person has essentially lost
More informationSchizoaffective Disorder
Roseanna Parkhurst-Gatewood MSN FNP-BC, PMHNP-BC DSM-5 diagnostic criteria for schizoaffective disorder 3 A. An uninterrupted period of illness during which there is a major mood episode (major depressive
More informationNATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE
NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Psychosis and schizophrenia in children and young people: recognition and management 1.1 Short title Psychosis and schizophrenia
More informationCaregiver Burden and Psychopathology in Schizophrenia : A Cross Sectional Study
Original Article 1 Institute of Mental Health Erragadda, Hyderabad Telangana. 2 Chalmeda Anand Rao Institute of Medical Sciences, Karimnagar Telangana. 3 Resident in Psychiatry 4 Institute of Mental Health
More informationNoncompliance with Treatment among Psychiatric Patients in Kuwait
Original Paper Med Principles Pract 1998;7:28 32 Received: December 12, 1996 Revised: March 22, 1997 Abdullahi A. Fido Abdulrazik M. Husseini Faculty of Medicine, Kuwait University, Kuwait Noncompliance
More informationADVANCED BEHAVIORAL HEALTH, INC. Clinical Level of Care Guidelines
The Clinical Level of Care Guidelines contained on the following pages have been developed as a guide to assist care managers, physicians and providers in making medical necessity decisions about the least
More informationSchizophrenia: Early Intervention
Focus on CME at The University of Western Ontario Schizophrenia: Early Intervention Rahul Manchanda, MD, MRCPsych, FRCP(C); and Ross M.G. Norman, PhD, CPsych Presented at A Psychiatric Update 2003, Regional
More informationTHE STABILITY OF SYMPTOMS AND SYNDROMES IN CHRONIC SCHIZOPHRENIC PATIENTS MILIND BORDE 1, ELIZABETH J.B. DAVIS 1 AND L.N. SHARMA 2
Indian J. Psychiat. 1992, 34(2), 133-139 THE STABILITY OF SYMPTOMS AND SYNDROMES IN CHRONIC SCHIZOPHRENIC PATIENTS MILIND BORDE 1, ELIZABETH J.B. DAVIS 1 AND L.N. SHARMA 2 36 chronic schizophrenic patients
More informationCOPING STRATEGIES OF THE RELATIVES OF SCHIZOPHRENIC PATIENTS
Indian Journal of Psychiatry, 2002,44(1 ),9-13 COPING STRATEGIES OF THE RELATIVES OF SCHIZOPHRENIC PATIENTS R.CHANDRASEKARAN, SIVAPRAKASH B.& S.R JAYESTRI ABSTRACT Families caring for a member with a chronic
More informationSocial Factors and Psychopathology in Epilepsy
ORIGINAL ARTICLE Social Factors and Psychopathology in Epilepsy N. Cyriac, P.N. Sureshkumar, A.M. Kunhikoyamu, A.S. Girija* Departments of Psychiatry and Neurology* Medical College Calicut, Kerala, India.
More informationTactile, Olfactory, and Gustatory Hallucinations in Psychotic Disorders: A Descriptive Study
Original Article 383 Tactile, Olfactory, and Gustatory Hallucinations in Psychotic Disorders: A Descriptive Study Kathryn E Lewandowski, 1,2 PhD, Joseph DePaola, 1,2 BA, Gamze B Camsari, 1 MD, Bruce M
More informationRole of Clozapine in Treatment-Resistant Schizophrenia
Disease Management and Treatment Strategies Elkis H, Meltzer HY (eds): Therapy-Resistant Schizophrenia. Adv Biol Psychiatry. Basel, Karger, 2010, vol 26, pp 114 128 Role of Clozapine in Treatment-Resistant
More informationEfficacy of modified compliance therapy for schizophrenia patients
Original article Efficacy of modified compliance therapy for schizophrenia patients Victoria Omranifard 1, Mojgan Karahmadi 2, Zahra Jannesari 3, Mohammad Maracy 4 1 Associate Professor, Psychosomatic
More informationRelationship between Positive and Negative Symptoms of Schizophrenia and Psychotic Depression with Risk of Suicide
Original Article Relationship between Positive and Negative Symptoms of Schizophrenia and Psychotic Depression with Risk of Suicide Ebrahim Abdollahian, MD *, Morterza Modares Gharavi, PhD * Atefeh Soltanifar,
More informationChallenges to Recovery Following Early Psychosis: Implications of Recovery Rate and Timing
Challenges to Recovery Following Early Psychosis: Implications of Recovery Rate and Timing Mental Health Exchange Group December 3, 2014 W Joy Maddigan, PhD RN Background One component [the quantitative
More informationAuditory hallucination coping techniques and their relationship to psychotic symptomatology
Psychiatry and Clinical Neurosciences (2007), 61, 640 645 doi:10.1111/j.1440-1819.2007.01741.x Regular Article Auditory hallucination coping techniques and their relationship to psychotic symptomatology
More informationCommunity Services - Eligibility
Community Services - Eligibility In order for DMH to reimburse care, the individual must meet both financial and clinical eligibility criteria. These criteria are described in detail in the DMH provider
More informationIndividualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool
Copyright John Donoghue 2015 Individualising antipsychotic treatment for patients with schizophrenia John Donoghue Liverpool Copyright John Donoghue 2015 QUESTIONS Why do outcomes in schizophrenia remain
More informationResearch Article JIACAM Vol. 1, No. 3, Article 6
Research Article JIACAM Vol. 1, No. 3, Article 6 Clinical Profile of Childhood Onset Schizophrenia in India* I. Sharma 1, D. Giri 2, Anna Dutta 3, P. Mazumder 4 & Mrs Anuradha 5 Department of Psychiatry
More informationSupplementary Online Content
Supplementary Online Content Subotnik KL, Casaus LR, Ventura J, et al. Long-acting injectable risperidone for relapse prevention and control of breakthrough symptoms after a recent first episode of schizophrenia:
More informationNovember 2014 MRC2.CORP.X.00004
This program is paid for by Otsuka America Pharmaceutical, Inc. and Lundbeck, LLC. The speaker is a paid consultant of Otsuka America Pharmaceutical, Inc. advice or professional diagnosis. Users seeking
More informationSELECTED EPIDEMIOLOGICAL ASPECTS OF SCHIZOPHRENIA: A CROSS SECTIONAL STUDY AT TERTIARY CARE HOSPITAL IN MAHARASHTRA
Original Article SELECTED EPIDEMIOLOGICAL ASPECTS OF SCHIZOPHRENIA: A CROSS SECTIONAL STUDY AT TERTIARY CARE HOSPITAL IN MAHARASHTRA Madhura D Ashturkar 1, Jaggnath V Dixit 2 Financial Support: None declared
More informationChapter 1.4. Intermittent neuroleptic treatment is a risk factor for tardive dyskinesia
Intermittent neuroleptic treatment is a risk factor for tardive dyskinesia The Curaçao Extrapyramidal Syndromes Study: III. Peter N. van Harten (1,3), Hans W. Hoek (2), Glenn E. Matroos (3), Maarten Koeter
More informationIntroduction. original article. Camilla Callegari Ivano Caselli Marta Ielmini Simone Vender E-bPC
original article Camilla Callegari Ivano Caselli Marta Ielmini Simone Vender Department of Clinical and Experimental Medicine, Section of Psychiatry, University of Insubria, Varese, Italy Influence of
More information8/22/2016. Contemporary Psychiatric-Mental Health Nursing Third Edition. Features of Schizophrenia. Features of Schizophrenia (cont'd)
Contemporary Psychiatric-Mental Health Nursing Third Edition CHAPTER 16 Schizophrenia Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties, but can be as
More informationEffectiveness of Cognitive Behaviour Therapy on Patients Suffering From Depression
The International Journal of Indian Psychology ISSN 2348-5396 (e) ISSN: 2349-3429 (p) Volume 3, Issue 4, No. 64, DIP: 18.01.119/20160304 ISBN: 978-1-365-32519-9 http://www.ijip.in July-September, 2016
More informationThe effect of rehabilitation of schizophrenic patients on their family atmosphere and the emotional well-being of caregivers
Eur. J. Psychiat. Vol. 19, N. 1, (55-64) 2005 Key words: Schizophrenia, Rehabilitation, Wellbeing, Caregiver, Family. The effect of rehabilitation of schizophrenic patients on their family atmosphere and
More informationContemporary Psychiatric-Mental Health Nursing. Features of Schizophrenia. Features of Schizophrenia - continued
Contemporary Psychiatric-Mental Health Nursing Chapter 16 Schizophrenia and Other Psychotic Disorders Features of Schizophrenia Prevalence in U.S. is 1.1%. Average onset is late teens to early twenties,
More informationNatural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort
Natural Course of Schizophrenic Disorders: A 15-Year Followup of a Dutch Incidence Cohort by Durk Wiersma, Fokko J. Nienhuis, Cees J. Slooff, and Robert Qiel Abstract Data are presented on the 15-year
More informationADMINISTRATIVE POLICY AND PROCEDURE
Page 1 of 6 SECTION: Medical SUBJECT: Electroconvulsive Therapy (ECT) DATE OF ORIGIN: 10/1/96 REVIEW DATES: 7/1/98, 10/1/99, 7/1/02, 7/1/04, 10/1/05, 5/1/09, 1/3/13, 7/1/15, 8/1/16 EFFECTIVE DATE: 3/24/17
More informationA study of clinico-demographic profile of patients with dissociative disorder
Journal of College of Medical Sciences-Nepal, 2012, Vol-8, No-3, 30-35 Original Article A study of clinico-demographic profile of patients with dissociative disorder SK Shah Lecturer, Department of Psychiatry,
More informationDate: Dear Mental Health Professional,
Date: Dear Mental Health Professional, Attached is the Referral Form required to receive PRP services from Mosaic Community Services. The following is required to complete the application process: Completed
More informationEffect of family intervention on functioning among patients with chronic schizophrenia
Original article Sreeja, I: Effect of family intervention on functioning Effect of family intervention on functioning among patients with chronic schizophrenia Sreeja I Email: sreeja009@rediffmail.com
More informationAntipsychotic treatment, psychoeducation & regular follow up as a public health strategy for schizophrenia: Results from a prospective study
Indian J Med Res 146, July 2017, pp 34-41 DOI: 10.4103/ijmr.IJMR_838_15 Quick Response Code: Antipsychotic treatment, psychoeducation & regular follow up as a public health strategy for schizophrenia:
More informationGoal: To recognize and differentiate different forms of psychopathology that involve disordered thinking and reasoning and distorted perception
Goal: To recognize and differentiate different forms of psychopathology that involve disordered thinking and reasoning and distorted perception Psychotic disorders, or psychoses, are among the most serious
More informationPreventing relapse in schizophrenia: a real priority or only a tick-box exercise? John Donoghue Liverpool
Preventing relapse in schizophrenia: a real priority or only a tick-box exercise? John Donoghue Liverpool L imagination est plus important que le savoir Albert Einstein Copyright John Donoghue 2013 These
More informationSchizophrenia and the Psychoses
Schizophrenia and the Psychoses Taking leave of one s senses Students of schizophrenia need to study and understand: Clinical presentation via case studies Terms and Definitions Biological features Prognosis
More informationORIGINAL ARTICLE. A Program for Relapse Prevention in Schizophrenia
A Program for Relapse Prevention in Schizophrenia A Controlled Study ORIGINAL ARTICLE Marvin I. Herz, MD; J. Steven Lamberti, MD; Jim Mintz, PhD; Ruth Scott, MS, RN, CS; Susan P. O Dell, MS, RN, CS; Lisa
More informationORIGINAL RESEARCH Key Words: psychometric evaluation, obsessive-compulsive disorder, co-morbidity, assessment
025-030_PB_V39N1_de_Haan.qxd 9/21/06 5:35 PM Page 25 ORIGINAL RESEARCH Key Words: psychometric evaluation, obsessive-compulsive disorder, co-morbidity, assessment Reliability and Validity of the Yale-Brown
More informationSCHIZOPHRENIA AN OVERVIEW
SCHIZOPHRENIA AN OVERVIEW Compiled by Campbell M Gold (2004) CMG Archives http://campbellmgold.com IMPORTANT The health information contained herein is not meant as a substitute for advice from your physician,
More informationI received help from Bosch Health Care
John Kasckow, MD, PhD VA Pittsburgh Health Care System Western Psychiatric Institute and Clinic, UPMC VA Pittsburgh Health Care System I received help from Bosch Health Care 1 Diagnoses of Interest Early
More informationABSTRACT. Keywords: Duration of untreated psychosis, First episode psychosis, Premorbid functioning
Research Report RELATION BETWEEN CLINICAL AND SOCIAL VARIABLES AND DURATION OF UNTREATED PSYCHOSIS IN FIRST EPISODE PSYCHOSIS Ganesh Kini 1*, Harish M Tharayil 2, KS Prabhavathy 3, Nishanth J Haridas 4
More informationPsychosis. Paula Gibbs, MD Department of Psychiatry University of Utah
Psychosis Paula Gibbs, MD Department of Psychiatry University of Utah Psychotic Symptoms Psychosis in a broad sense, signifies impaired reality testing ability Symptoms include: hallucinations, delusions,
More informationJ. Indian Assoc. Child Adolesc. Ment. Health 2010; 6(3): Original Article
49 J. Indian Assoc. Child Adolesc. Ment. Health 2010; 6(3):49-54 Original Article Clinical Features and Outcome of Conversion Disorders in Children and Adolescents Sujata Sethi, Raghu Gandhi*, Dharmendra**,
More informationQuality of life in caregivers of persons with mental retardation and chronic schizophrenia: A comparative study
Original article Quality of life in caregivers of persons with mental retardation and chronic schizophrenia: A comparative study Moushumi Purkayastha, BS Chavan, Suresh Kumar Abstract Introduction: The
More informationSchizophrenia. Nikita Verma 2017 Page 1
Schizophrenia It is a severe psychiatric disorder with symptoms of emotional instability, detachment from reality and withdrawal into self. It is an umbrella term used to outline a range of different psychiatric
More informationCondensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia
Condensed Clinical Practice Guideline Treatment Of Patients With Schizophrenia I. Key Points a. Schizophrenia is a chronic illness affecting all aspects of person s life i. Treatment Planning Goals 1.
More informationDiagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year longitudinal study of schizophrenia and bipolar disorder
Available online at www.sciencedirect.com Comprehensive Psychiatry 52 (2011) 126 131 www.elsevier.com/locate/comppsych Diagnostic and prognostic significance of Schneiderian first-rank symptoms: a 20-year
More informationPsychopathology in patients with schizophrenia attending a psychiatry outpatient clinic at a tertiary care hospital
Original paper Psychopathology in patients with schizophrenia attending a psychiatry outpatient clinic at a tertiary care hospital Hiranya Wijesundara, Madhubhashinee Dayabandara, Arjuna Ellepola and Raveen
More informationINTRODUCTION TO MENTAL HEALTH. PH150 Fall 2013 Carol S. Aneshensel, Ph.D.
INTRODUCTION TO MENTAL HEALTH PH150 Fall 2013 Carol S. Aneshensel, Ph.D. Topics Subjective Experience: From the perspective of mentally ill persons Context Public attitudes toward the mentally ill Definition
More informationSCHRES1520. Schizophrenia Research 000 (2001) 000±000. Affective reactivity of language and right-ear advantage in schizophrenia
SCHRES1520 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 Abstract Affective reactivity of language and right-ear
More informationHandout for the Neuroscience Education Institute (NEI) online activity: First-Episode Schizophrenia: Setting the Stage for Successful Outcomes
Handout for the Neuroscience Education Institute (NEI) online activity: First-Episode Schizophrenia: Setting the Stage for Successful Outcomes Learning Objectives Initiate low-dose antipsychotic medication
More informationPsychopathology, Disability & Family Burden of Patients with Schizophrenia and Bipolar Affective Disorders -A Comparison
Original article DOI: http://dx.doi.org/10.18320/jimd/201603.0112 JOURNAL OF INTERNATIONAL MEDICINE AND DENTISTRY To search..to know...to share p-issn: 2454-8847 e-issn: 2350-045X Psychopathology, Disability
More informationA Comparison of Clinical Features among Patients Suffering from Depression in HIV Positive and HIV Negative Cases
Original Article A Comparison of Clinical Features among Patients Suffering from Depression in HIV Positive and HIV Negative Cases Rajdeep Kaur, Ramandeep Kaur Civil Hospital, Gurdaspur, Punjab Abstract
More informationCLINICAL EFFECTIVENESS
CLINICAL EFFECTIVENESS Faculty Dr Ashok Malla Dr Rahul Manchanda Dr Toba Oluboka Dr Thomas Raedler Dr Marc-André Roy Dr Phil Tibbo Dr Richard Williams Audience Question What do you think Clinical Effectiveness
More informationCLINICAL EFFECTIVENESS
CLINICAL EFFECTIVENESS Faculty Dr Ashok Malla Dr Rahul Manchanda Dr Toba Oluboka Dr Thomas Raedler Dr Marc-André Roy Dr Phil Tibbo Dr Richard Williams Audience Question What do you think Clinical Effectiveness
More informationVALIDATION IN PROCESS
The Scale for Early Psychosis Relapse Risk Assessment (SEPRRA) Clinician PATIENT NAME (Last, First) Assessment Date (DD/MM/YYYY) Assessment Completed By: DEMOGRAPHICS AND CLINICAL INFORMATION Gender Male
More informationDESIGN TYPE AND LEVEL OF EVIDENCE: Randomized controlled trial, Level I
CRITICALLY APPRAISED PAPER (CAP) Hasan, A. A., Callaghan, P., & Lymn, J. S. (2015). Evaluation of the impact of a psychoeducational intervention for people diagnosed with schizophrenia and their primary
More informationTracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health
Schizophrenia: What Do We Know? Where Do We Go From Here? Tracey G. Skale, MD Chief Medical Officer Greater Cincinnati Behavioral Health Objectives Participants will be able to: Understand the clinical
More informationExpectations Of Patients Using Mental Health Services
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 16, Issue 8 Ver. I (Aug. 2017), PP 33-37 www.iosrjournals.org Expectations Of Patients Using Mental Health
More informationCourse and Outcome for Schizophrenia Versus Other Psychotic Patients: A Longitudinal Study
Course and Outcome for Schizophrenia Versus Other Psychotic Patients: A Longitudinal Study Abstract by Martin Harrow, James R. Sands, Marshall L. Silverstein, and Joseph F. Qoldberg We studied 276 patients
More informationDisease Modification in Schizophrenia: Overview of the Issues. ISCTM February 18 th 2014 Ravi Anand, MD Switzerland
Disease Modification in Schizophrenia: Overview of the Issues ISCTM February 18 th 2014 Ravi Anand, MD Switzerland Need for a New Treatment Paradigm in Schizophrenia Sixty years after approval for the
More informationBy Jason H. King DECONSTRUCTING THE DSM-5 ASSESSMENT AND DIAGNOSIS OF SCHIZOPHRENIA SPECTRUM DISORDERS THE NEW LANDSCAPE
DECONSTRUCTING THE DSM-5 By Jason H. King ASSESSMENT AND DIAGNOSIS OF SCHIZOPHRENIA SPECTRUM DISORDERS Happy New Year as you engage in your counseling, research, supervision or educational endeavors. I
More informationLOUISIANA MEDICAID PROGRAM ISSUED: 04/13/10 REPLACED: 03/01/93 CHAPTER 13: MENTAL HEALTH CLINICS SECTION13.1: SERVICES PAGE(S) 9 SERVICES
SERVICES The clinic services covered under the program are defined as those preventive, diagnostic, therapeutic, rehabilitative, or palliative items or services that are furnished to an outpatient by or
More informationEffect of Instructional Module on Drug Adherence in Terms of Attitude among Patients with Schizophrenia
Original Article NUJHS Vol. 6, No.1, March 2016, ISSN 2249-7110 Effect of Instructional Module on Drug Adherence in Terms of Attitude among Patients with Schizophrenia 1 S. Mary Metilda, S. Santhi² & G.
More informationA study of the predictive factors of diagnostic instability of ATPD in Indian population
Original article: A study of the predictive factors of diagnostic instability of ATPD in Indian population 1Dr.Sonia Malhotra, 2 Dr. Pankaj B.Borade, 3 Dr. Jay P.Kumawat, 4 Dr.YogeshSatija 1M.D. Psychiatry,
More informationMethods. Outcomes of interest and tools used. Study design and location. Participants. Statistical analysis
ht t p: / / doi. or g/ 10. 4038/ s l j ps yc. v8i 2. 8155 A study of psychiatric morbidity and associated factors in carers of patients with schizophrenia in Nigeria functioning were risk factors for psychiatric
More informationWorking with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers
Working with Clients Experiencing a First Episode of Psychosis: Considerations for Prescribers Tuesday, February 23, 2016 2pm Eastern Delbert Robinson, M.D. Professor of Psychiatry and Molecular Medicine
More informationAppointment attendance in patients with schizophrenia
Appointment attendance in patients with schizophrenia Practice points Appointment attendance in patients with schizophrenia is a significant and understudied issue. A sizable percentage of patients with
More informationPsychosis, Mood, and Personality: A Clinical Perspective
Psychosis, Mood, and Personality: A Clinical Perspective John R. Chamberlain, M.D. Assistant Director, Psychiatry and the Law Program Assistant Clinical Professor University of California San Francisco
More informationLongitudinal Courses of Thought Disorder in Schizophrenia and Schizoaffective Disorder
Longitudinal Courses of Thought Disorder in Schizophrenia and Schizoaffective Disorder Abstract This research examined the longitudinal courses of thought disorder hi schizophrenia, schlzoaffective disorder,
More informationRaman Krishnan 1,*, Sharma PSVN 2. Manipal. *Corresponding Author:
Original Research Article A comparative study of clinical correlates of bipolar mixed state with bipolar manic and bipolar depressed state in a general hospital psychiatry setting Raman Krishnan 1,*, Sharma
More informationEarly identification of neurobiological markers of remission. Michael Bodnar, PhD Ashok K. Malla, MD Martin Lepage, PhD
Early identification of neurobiological markers of remission Michael Bodnar, PhD Ashok K. Malla, MD Martin Lepage, PhD Outline Why study remission? Defining remission Data collection Results neurocognition
More informationClozapine Treatment and Predictors of Response in Patients with Schizophrenia
KISEP Original Article Clinical Psychopharmacology and Neuroscience 2003; 1: 22-6 Clozapine Treatment and Predictors of Response in Patients with Schizophrenia Chul Eung Kim, Sang Eun Shin, Min Hee Kang
More informationTHERAPEUTIC AND EVOLUTIVE ASPECTS IN SCHIZOPHRENIA
UNIVERSITY OF MEDICINE AND PHARMACY OF CRAIOVA THERAPEUTIC AND EVOLUTIVE ASPECTS IN SCHIZOPHRENIA ABSTRACT Ph.D. Coordinator Professor Dragoș MARINESCU PhD Student: Mihai MUTICĂ Craiova 2016 TABLE OF CONTENTS
More informationPreferred Practice Guidelines Bipolar Disorder in Children and Adolescents
BadgerCare Plus Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice
More informationFactors associated with treatment lag in mental health care
Buckshey award Factors associated with treatment lag in mental health care Rohit Garg, Ajeet Sidana, Bir Singh Chavan Abstract Background: Despite the substantial distress and impairment caused by mental
More informationPsychological Disorders (mental illnesses): A Little History What are psychological disorders? What are some major classes of psychological disorders?
Psychological Disorders (mental illnesses): A Little History What are psychological disorders? What are some major classes of psychological disorders? Through the ages, people suffering from psychological
More informationRUNNING HEAD: Efficacy, Long Acting Injectable Antipsychotics and Schizophrenia 1
RUNNING HEAD: Efficacy, Long Acting Injectable Antipsychotics and Schizophrenia 1 Efficacy of Long Acting Injectable Antipsychotics in Early Onset Schizophrenia Linda Pietras RN-BC Mercyhurst University
More informationIs Aristada (Aripiprazole Lauroxil) a Safe and Effective Treatment For Schizophrenia In Adult Patients?
Philadelphia College of Osteopathic Medicine DigitalCommons@PCOM PCOM Physician Assistant Studies Student Scholarship Student Dissertations, Theses and Papers 12-2016 Is Aristada (Aripiprazole Lauroxil)
More informationAt Issue: Management of Medication Noncompliance in Schizophrenia by Families in India
At Issue: Management of Medication Noncompliance in Schizophrenia by Families in India by Tirupati N. Srinivasan and Rangaswamy Thara The At Issue section of the Schizophrenia Bulletin contains viewpoints
More informationReligious Beliefs and Their Relevance for Adherence to Treatment in Mental Illness: A Review
Religious Beliefs and Their Relevance for Adherence to Treatment in Mental Illness: A Review Pawel Zagozdzon, Magdalena Wrotkowska Department of Hygiene and Epidemiology Medical University of Gdansk 1
More informationAffective reactivity of speech and emotional experience in patients with schizophrenia
Schizophrenia Research 69 (2004) 7 14 www.elsevier.com/locate/schres Affective reactivity of speech and emotional experience in patients with schizophrenia Alex S. Cohen*, Nancy M. Docherty Department
More informationA Study of Prevalence and Clinical Correlates of Nicotine Dependence Among Patients With Bipolar Disorder
IOSR Journal of Dental and Medical Sciences (IOSR-JDMS) e-issn: 2279-0853, p-issn: 2279-0861.Volume 17, Issue 9 Ver. 13 (September. 2018), PP 05-21 www.iosrjournals.org A Study of Prevalence and Clinical
More informationClass Update: Oral Antipsychotics
Copyright 2012 Oregon State University. All Rights Reserved Drug Use Research & Management Program Oregon State University, 500 Summer Street NE, E35 Salem, Oregon 97301-1079 Phone 503-947-5220 Fax 503-947-1119
More informationORIGINAL ARTICLE. AP J Psychological Medicine Vol. 15 (1) January-June 2014
81 ORIGINAL ARTICLE A study of non-compliance with pharmacotherapy in psychiatric patients Sadia Sultan, 1 MD, Sadanand S Chary, 2 MD, Sharband R,, Vemula,3, MD 1 Assistant professor of Psychiatry, 2 Assistant
More informationThe Diagnostic Stability of DSM-IV Diagnoses: An Examination of Major Depressive Disorder, Bipolar I Disorder, and Schizophrenia in Korean Patients
Original Article pissn 1738-1088 / eissn 2093-4327 Clinical Psychopharmacology and Neuroscience 2011;9(3):117-121 Copyrightc 2011, Korean College of Neuropsychopharmacology The Diagnostic Stability of
More informationIn the general population, men are more physically aggressive
Article Gender Differences in Violent Behaviors: Relationship to Clinical Symptoms and Psychosocial Factors Menahem Krakowski, M.D., Ph.D. Pal Czobor, Ph.D. Objective: Men are more violent than women in
More informationSCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2
Psychiatrická klinika LFUK a UNB, Bratislava SCHIZOPHRENIA SPECTRUM DISORDERS Psychiatry 2 Practical # 2 Author: MUDr. Ľubomíra Izáková, PhD. Supervisor: doc. MUDr. Ján Pečeňák, CSc. Podporené grantom
More information